Pregnane X receptor polymorphisms associated with human diseases

Expert Opinion on Therapeutic Targets

Volumn 17, Issue 10, 2013, Pages 1167-1177

  Kotta Loizou, Ioly ^a   Patsouris, Efstratios ^a   Theocharis, Stamatios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

AIDS; Cancer; Drug clearance; Inflammatory bowel disease; Polymorphisms; Pregnane X receptor

Indexed keywords

ANTICONVULSIVE AGENT; CYCLOSPORIN A; EFAVIRENZ; FOSAMPRENAVIR; LOPINAVIR; NELFINAVIR; PREGNANE X RECEPTOR; RIFAMPICIN; RIFAXIMIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BARRETT ESOPHAGUS; BREAST CANCER; CANCER RISK; COLON CANCER; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG TARGETING; ENTERITIS; EPILEPSY; GENETIC POLYMORPHISM; HUMAN; INTRAHEPATIC CHOLESTASIS; INTRON; KIDNEY TRANSPLANTATION; LYMPHOMA; MALARIA; MEDICAL LITERATURE; MODULATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PREGNANCY DISORDER; PRIMARY BILIARY CIRRHOSIS; REFLUX ESOPHAGITIS; REVIEW; RISK ASSESSMENT; TREATMENT RESPONSE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; BARRETT ESOPHAGUS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; LIVER DISEASES; NEOPLASMS; POLYMORPHISM, GENETIC; RECEPTORS, STEROID;

EID: 84884576295     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2013.823403     Document Type: Review

References (89)

1. Blumberg B, Sabbagh W Jr, Juguilon H, et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev 1998;12(20):3195-205
2. Kliewer SA, Moore JT, Wade L, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 1998;92(1):73-82
3. Meyer zu Schwabedissen HE, Kim RB. Hepatic OATP1B transporters and nuclear receptors PXR and CAR: interplay, regulation of drug disposition genes, and single nucleotide polymorphisms. Mol Pharm 2009;6(6):1644-61
4. Zhang J, Kuehl P, Green ED, et al. The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants. Pharmacogenetics 2001;11(7):555-72
5. Bertilsson G, Heidrich J, Svensson K, et al. Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction. Proc Natl Acad Sci USA 1998;95(21):12208-13
6. Lamba V, Yasuda K, Lamba JK, et al. PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators. Toxicol Appl Pharmacol 2004;199(3):251-65
7. Dotzlaw H, Leygue E, Watson P, et al. The human orphan receptor PXR messenger RNA is expressed in both normal and neoplastic breast tissue. Clin Cancer Res 1999;5(8):2103-7
8. Lehmann JM, McKee DD, Watson MA, et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 1998;102(5):1016-23
9. Carnahan VE, Redinbo MR. Structure and function of the human nuclear xenobiotic receptor PXR. Curr Drug Metab 2005;6(4):357-67
10. Watkins RE, Wisely GB, Moore LB, et al. The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 2001;292(5525):2329-33
11. Gillam EM. The PXR ligand-binding domain: how to be picky and promiscuous at the same time. Trends Pharmacol Sci 2001;22(9):448
12. Kliewer SA, Goodwin B, Willson TM. The nuclear pregnane X receptor: a key regulator of xenobiotic metabolism. Endocr Rev 2002;23(5):687-702
13. Desai PB, Nallani SC, Sane RS, et al. Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen. Drug Metab Dispos 2002;30(5):608-12
14. Tabb MM, Sun A, Zhou C, et al. Vitamin K2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem 2003;278(45):43919-27
15. Landes N, Pfluger P, Kluth D, et al. Vitamin E activates gene expression via the pregnane X receptor. Biochem Pharmacol 2003;65(2):269-73
16. Pacyniak EK, Cheng X, Cunningham ML, et al. The flame retardants, polybrominated diphenyl ethers, are pregnane X receptor activators. Toxicol Sci 2007;97(1):94-102
17. Coumoul X, Diry M, Barouki R. PXR-dependent induction of human CYP3A4 gene expression by organochlorine pesticides. Biochem Pharmacol 2002;64(10):1513-19
18. Goodwin B, Gauthier KC, Umetani M, et al. Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor. Proc Natl Acad Sci USA 2003;100(1):223-8
19. Xie W, Radominska-Pandya A, Shi Y, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci USA 2001;98(6):3375-80
20. Staudinger J, Liu Y, Madan A, et al. Coordinate regulation of xenobiotic and bile acid homeostasis by pregnane X receptor. Drug Metab Dispos 2001;29(11):1467-72
21. Moore LB, Parks DJ, Jones SA, et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 2000;275(20):15122-7
22. Jones SA, Moore LB, Shenk JL, et al. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 2000;14(1):27-39
23. Zhang B, Xie W, Krasowski MD. PXR: a xenobiotic receptor of diverse function implicated in pharmacogenetics. Pharmacogenomics 2008;9(11):1695-709
24. Staudinger JL, Goodwin B, Jones SA, et al. The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci USA 2001;98(6):3369-74
25. Klaassen CD, Slitt AL. Regulation of hepatic transporters by xenobiotic receptors. Curr Drug Metab 2005;6(4):309-28
26. Zhai Y, Pai HV, Zhou J, et al. Activation of pregnane X receptor disrupts glucocorticoid and mineralocorticoid homeostasis. Mol Endocrinol 2007;21(1):138-47
27. Zhou J, Febbraio M, Wada T, et al. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis. Gastroenterology 2008;134(2):556-67
28. Zhou J, Zhai Y, Mu Y, et al. A novel pregnane X receptor-mediated and sterol regulatory element-binding proteinindependent lipogenic pathway. J Biol Chem 2006;281(21):15013-20
29. Dai G, He L, Bu P, et al. Pregnane X receptor is essential for normal progression of liver regeneration. Hepatology 2008;47(4):1277-87
30. Nakamura K, Moore R, Negishi M, et al. Nuclear pregnane X receptor cross-talk with FoxA2 to mediate drug-induced regulation of lipid metabolism in fasting mouse liver. J Biol Chem 2007;282(13):9768-76
31. Xu Y, Hashizume T, Shuhart MC, et al. Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol 2006;69(1):56-65
32. Wang T, Ma X, Krausz KW, et al. Role of pregnane X receptor in control of all-trans retinoic acid (ATRA) metabolism and its potential contribution to ATRA resistance. J Pharmacol Exp Ther 2008;324(2):674-84
33. Marek CJ, Tucker SJ, Konstantinou DK, et al. Pregnenolone-16alpha- carbonitrile inhibits rodent liver fibrogenesis via PXR (pregnane X receptor)-dependent and PXR-independent mechanisms. Biochem J 2005;387(Pt 3):601-8
34. Zhou C, Tabb MM, Nelson EL, et al. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation. J Clin Invest 2006;116(8):2280-9
35. Dring MM, Goulding CA, Trimble VI, et al. The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease. Gastroenterology 2006;130(2):341-8; quiz 592
36. Langmann T, Moehle C, Mauerer R, et al. Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes. Gastroenterology 2004;127(1):26-40
37. Martinez A, Marquez A, Mendoza J, et al. Role of the PXR gene locus in inflammatory bowel diseases. Inflamm Bowel Dis 2007;13(12):1484-7
38. Forman BM. Polymorphisms in promiscuous PXR: an explanation for interindividual differences in drug clearance? Pharmacogenetics 2001;11(7):551-2
39. Shah YM, Ma X, Morimura K, et al. Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-kappaB target gene expression. Am J Physiol Gastrointest Liver Physiol 2007;292(4):G1114-22
40. Cheng J, Shah YM, Ma X, et al. Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. J Pharmacol Exp Ther 2010;335(1):32-41
41. Mencarelli A, Migliorati M, Barbanti M, et al. Pregnane-X-receptor mediates the anti-inflammatory activities of rifaximin on detoxification pathways in intestinal epithelial cells. Biochem Pharmacol 2010;80(11):1700-7
42. Amre DK, Mack DR, Israel D, et al. Investigation of associations between the pregnane-X receptor gene (NR1I2) and Crohn's disease in Canadian children using a gene-wide haplotype-based approach. Inflamm Bowel Dis 2008;14(9):1214-18
43. Lacher M, Kappler R, Schroepf S, et al. Nuclear pregnane X receptor single nucleotide polymorphism (-25385C/T) is not associated with inflammatory bowel disease in pediatric patients. J Pediatr Gastroenterol Nutr 2009;49(1):147-50
44. Andersen V, Christensen J, Ernst A, et al. Polymorphisms in NF-kappaB, PXR, LXR, PPARgamma and risk of inflammatory bowel disease. World J Gastroenterol 2011;17(2):197-206
45. Cave M, Deaciuc I, Mendez C, et al. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition. J Nutr Biochem 2007;18(3):184-95
46. Sookoian S, Castano GO, Burgueno AL, et al. The nuclear receptor PXR gene variants are associated with liver injury in nonalcoholic fatty liver disease. Pharmacogenet Genomics 2010;20(1):1-8
47. Falk GW. Barrett's esophagus. Gastroenterology 2002;122(6):1569-91
48. Jankowski JA, Harrison RF, Perry I, et al. Barrett's metaplasia. Lancet 2000;356(9247):2079-85
49. Richter JE. Importance of bile reflux in Barrett's esophagus. Dig Dis 2000;18(4):208-16
50. Triadafilopoulos G. Acid and bile reflux in Barrett's esophagus: a tale of two evils. Gastroenterology 2001;121(6):1502-6
51. van de Winkel A, Menke V, Capello A, et al. Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma. BMC Gastroenterol 2011;11:108
52. Van Mil SW, Milona A, Dixon PH, et al. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007;133(2):507-16
53. Zimmer V, Mullenbach R, Simon E, et al. Combined functional variants of hepatobiliary transporters and FXR aggravate intrahepatic cholestasis of pregnancy. Liver Int 2009;29(8):1286-8
54. Castano G, Burgueno A, Fernandez Gianotti T, et al. The influence of common gene variants of the xenobiotic receptor (PXR) in genetic susceptibility to intrahepatic cholestasis of pregnancy. Aliment Pharmacol Ther 2009;31(5):583-92
55. Long SA, Van de Water J, Gershwin ME. Antimitochondrial antibodies in primary biliary cirrhosis: the role of xenobiotics. Autoimmun Rev 2002;1(1-2):37-42
56. Long SA, Quan C, Van de Water J, et al. Immunoreactivity of organic mimeotopes of the E2 component of pyruvate dehydrogenase: connecting xenobiotics with primary biliary cirrhosis. J Immunol 2001;167(5):2956-63
57. Leung PS, Quan C, Park O, et al. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies. J Immunol 2003;170(10):5326-32
58. Kimura Y, Selmi C, Leung PS, et al. Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis. Hepatology 2005;41(1):55-63
59. Burk O, Arnold KA, Nussler AK, et al. Antimalarial artemisinin drugs induce cytochrome P450 and MDR1 expression by activation of xenosensors pregnane X receptor and constitutive androstane receptor. Mol Pharmacol 2005;67(6):1954-65
60. Ferreira PE, Veiga MI, Cavaco I, et al. Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa. Ther Drug Monit 2008;30(1):10-15
61. Horwitz K, Clarke C. Estrogens and progestins in mammary development and neoplasia. Introduction. J Mammary Gland Biol Neoplasia 1998;3(1):1-2
62. Meyer zu Schwabedissen HE, Tirona RG, Yip CS, et al. Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res 2008;68(22):9338-47
63. Justenhoven C, Schaeffeler E, Winter S, et al. Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk. Breast Cancer Res Treat 2011;125(2):563-9
64. Abbas S, Brauch H, Chang-Claude J, et al. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy. Int J Cancer 2010;126:2935-46
65. Huxley RR, Ansary-Moghaddam A, Clifton P, et al. The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 2009;125(1):171-80
66. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 2009;124(10):2406-15
67. Tsoi KK, Pau CY, Wu WK, et al. Cigarette smoking and the risk of colorectal cancer: a meta-analysis of prospective cohort studies. Clin Gastroenterol Hepatol 2009;7(6):682-8; e1-5
68. Santarelli RL, Pierre F, Corpet DE. Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer 2008;60(2):131-44
69. Andersen V, Ostergaard M, Christensen J, et al. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 MDR1 and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. BMC Cancer 2009;9:407
70. King CR, Xiao M, Yu J, et al. Identification of NR1I2 genetic variation using resequencing. Eur J Clin Pharmacol 2007;63(6):547-54
71. Andersen V, Christensen J, Overvad K, et al. Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes. BMC Cancer 2010;10:484
72. Agundez JA. Polymorphisms of human N-acetyltransferases and cancer risk. Curr Drug Metab 2008;9(6):520-31
73. Leslie EM, Deeley RG, Cole SP. Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters. Toxicology 2001;167(1):3-23
74. Sheweita SA, Tilmisany AK. Cancer and Phase II drug-metabolizing enzymes. Curr Drug Metab 2003;4(1):45-58
75. Singh MS, Michael M. Role of xenobiotic metabolic enzymes in cancer epidemiology. Methods Mol Biol 2009;472:243-64
76. Campa D, Butterbach K, Slager SL, et al. A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk. Int J Cancer 2011;131(4):803-12
77. Haerian BS, Lim KS, Mohamed EH, et al. Lack of association of ABCB1 and PXR polymorphisms with response to treatment in epilepsy. Seizure 2011;20(5):387-94
78. Sandanaraj E, Lal S, Selvarajan V, et al. PXR pharmacogenetics: association of haplotypes with hepatic CYP3A4 and ABCB1 messenger RNA expression and doxorubicin clearance in Asian breast cancer patients. Clin Cancer Res 2008;14(21):7116-26
79. Tham LS, Holford NH, Hor SY, et al. Lack of association of single-nucleotide polymorphisms in pregnane X receptor, hepatic nuclear factor 4alpha, and constitutive androstane receptor with docetaxel pharmacokinetics. Clin Cancer Res 2007;13(23):7126-32
80. Lim HS, Ju Lee H, Seok Lee K, et al. Clinical implications of CYP2D6 genotypes predictive of tamoxifen pharmacokinetics in metastatic breast cancer. J Clin Oncol 2007;25(25):3837-45
81. Siccardi M, D'Avolio A, Baietto L, et al. Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-T) with reduced concentrations of unboosted atazanavir. Clin Infect Dis 2008;47(9):1222-5
82. Schipani A, Siccardi M, D'Avolio A, et al. Population pharmacokinetic modeling of the association between 63396C- T pregnane X receptor polymorphism and unboosted atazanavir clearance. Antimicrob Agents Chemother 2010;54(12):5242-50
83. Wyen C, Hendra H, Siccardi M, et al. Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens. J Antimicrob Chemother 2011;66(9):2092-8
84. Svard J, Spiers JP, Mulcahy F, et al. Nuclear receptor-mediated induction of CYP450 by antiretrovirals: functional consequences of NR1I2 (PXR) polymorphisms and differential prevalence in whites and sub-Saharan Africans. J Acquir Immune Defic Syndr 2010;55(5):536-49
85. Press RR, Ploeger BA, den Hartigh J, et al. Explaining variability in ciclosporin exposure in adult kidney transplant recipients. Eur J Clin Pharmacol 2010;66(6):579-90
86. Lamba J, Lamba V, Strom S, et al. Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression. Drug Metab Dispos 2008;36(1):169-81
87. Wahli W. A gut feeling of the PXR, PPAR and NF-kappaB connection. J Intern Med 2008;263(6):613-19
88. Koutsounas I, Patsouris E, Theocharis S, Pregnane X. Receptor and human malignancy. Histol Histopathol 2013
89. Koutsounas I, Theocharis S, Patsouris E, et al. Pregnane X. Receptor (PXR) at the crossroads of human metabolism and disease. Curr Drug Metab 2012